Glatiramer acetate

Self-reported adherence and safety from the MASTER-2 & CLICK-MS studies of cladribine in MS patients 3:21
Self-reported adherence and safety from the MASTER-2 & CLICK-MS studies of cladribine in MS patients
Emily Evans • 21 Feb 2023
Current recommendations on MS treatment during pregnancy 1:46
Current recommendations on MS treatment during pregnancy
Eva Kubala Havrdová • 27 Oct 2022
Managing MS relapses during pregnancy 2:25
Managing MS relapses during pregnancy
Kristen Krysko • 4 Apr 2022
Characterizing real-world outcomes among COVID-19 vaccinated patients with MS 2:07
Characterizing real-world outcomes among COVID-19 vaccinated patients with MS
Namita Tundia • 25 Feb 2022
How to approach MS treatment sequencing in a crowded therapeutic market 1:13
How to approach MS treatment sequencing in a crowded therapeutic market
Jeffrey Cohen • 24 Feb 2022
Humoral response to COVID-19 vaccination in patients with MS 6:28
Humoral response to COVID-19 vaccination in patients with MS
Celia Oreja-Guevara • 14 Oct 2021
Update on pediatric NMOSD and MOGAD 3:47
Update on pediatric NMOSD and MOGAD
Brenda Banwell • 26 Apr 2021
The content of VJNeurology is intended for healthcare professionals